Rote William E. 的 Form 4 申報
Travere Therapeutics, Inc.TVTX，2026/9/17 申報
- 申報編號
- 0001698262-26-000005
- 申報時間
- 2026/9/17 21:35 ET
- 交易日
- 2026/9/15-9/16
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 11 筆非衍生性交易、5 筆衍生性交易。公開市場賣出合計 $1,314 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Rote William E.CIK 0001698262 | 高階主管（Chief Research Officer） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/9/15 | Common Stock | M行使選擇權取得 | +39,000 | $25.25 | +$984,750 | 154,745 | 直接 | |
| 2026/9/15 | Common Stock | M行使選擇權取得 | +39,650 | $17.96 | +$712,114 | 194,395 | 直接 | |
| 2026/9/15 | Common Stock | S賣出處分 | −63,907 | $61.99F3 | −$3,961,850.56 | 130,488 | 直接 | |
| 2026/9/15 | Common Stock | S賣出處分 | −29,021 | $62.66F4 | −$1,818,316.56 | 101,467 | 直接 | |
| 2026/9/15 | Common Stock | S賣出處分 | −3,000 | $63.65F5 | −$190,952.4 | 98,467 | 直接 | |
| 2026/9/15 | Common Stock | S賣出處分 | −270 | $65.31 | −$17,633.7 | 98,197 | 直接 | |
| 2026/9/16 | Common Stock | M行使選擇權取得 | +350 | $17.96 | +$6,286 | 98,547 | 直接 | |
| 2026/9/16 | Common Stock | M行使選擇權取得 | +55,000 | $15.46 | +$850,300 | 153,547 | 直接 | |
| 2026/9/16 | Common Stock | M行使選擇權取得 | +57,500 | $26.88 | +$1,545,600 | 211,047 | 直接 | |
| 2026/9/16 | Common Stock | S賣出處分 | −65,104 | $63.12F6 | −$4,109,397.03 | 145,943 | 直接 | |
| 2026/9/16 | Common Stock | S賣出處分 | −47,746 | $63.61F7 | −$3,037,247.2 | 98,197 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/9/15 | Common Stock | M行使選擇權處分 | −39,000 | $0.00 | $0 | 0 | 直接 | |
| 2026/9/15 | Common Stock | M行使選擇權處分 | −39,650 | $0.00 | $0 | 350 | 直接 | |
| 2026/9/16 | Common Stock | M行使選擇權處分 | −350 | $0.00 | $0 | 0 | 直接 | |
| 2026/9/16 | Common Stock | M行使選擇權處分 | −55,000 | $0.00 | $0 | 0 | 直接 | |
| 2026/9/16 | Common Stock | M行使選擇權處分 | −57,500 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
The weighted average sale price for the transaction reported was $61.994, and the range of prices were between $61.405 and $62.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $62.6552 and the range of prices were between $62.41 and $63.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The weighted average sale price for the transaction reported was $63.6508, and the range of prices were between $63.49 and $63.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided
表 I 有 1 筆交易的價格引用這則附註。
- F6
The weighted average sale price for the transaction reported was $63.1205, and the range of prices were between $62.47 and $63.4650. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The weighted average sale price for the transaction reported was $63.6126, and the range of prices were between $63.47 and $63.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
表 I 有 1 筆交易的價格引用這則附註。